Project Oncology®

195 Episodo

1. Pancreatic Cancer: The Hunt to Catch a Silent Killer

   Publicado: 12/8/2017
2. FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

   Publicado: 28/7/2017
3. FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

   Publicado: 25/7/2017
4. Linking p53 Variation to Breast Cancer Risk in African American Women

   Publicado: 19/6/2017
5. FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

   Publicado: 30/5/2017
6. Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches

   Publicado: 23/5/2017
7. FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

   Publicado: 22/5/2017
8. FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

   Publicado: 18/5/2017
9. Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

   Publicado: 17/4/2017
10. Hot Topics in Breast Cancer Innovations

    Publicado: 6/2/2017
11. A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient

    Publicado: 2/2/2017
12. High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management

    Publicado: 20/4/2016
13. From Silent Killer to Treatable Disease: Improved Detection Methods for Ovarian Cancer

    Publicado: 7/3/2016
14. Are Practicing Ob-Gyn Oncologists on Your Speed Dial?

    Publicado: 8/2/2016
15. Nutrition & Breast Cancer Risk: Connecting the Dots with Emerging Evidence

    Publicado: 31/8/2015